查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466734

软骨修復/软骨再生市场：按治疗模式、应用和最终用户划分 - 全球预测 2024-2030

Cartilage Repair/Cartilage Regeneration Market by Treatment Mode (Cell-Based, Non-Cell-Based), Application (Fibrocartilage, Hyaline Cartilage), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

软骨修復/软骨再生市场规模预估2023年为18.3亿美元，2024年达20.6亿美元，预估2030年将达44.6亿美元，复合年增长率为13.55%。

软骨修復和再生是指各种旨在恢復受损关节软骨的功能和减轻疼痛的医疗治疗和程序。软骨是一种光滑、有弹性的组织。这种橡胶垫片覆盖并保护关节中长骨的末端，包括胸腔、耳朵、鼻子、支气管、椎间盘和身体的许多其他部位。软骨修復和再生市场包括旨在修復、再生和替换受损软骨的医疗程序、工具和治疗方法。关节炎和骨关节炎等骨关节疾病的流行，以及交通事故和运动相关伤害的快速增加正在推动市场成长。人们对软骨生理学、解剖学和修復技术的认识不断提高也推动了市场的发展。与软骨修復手术相关的成本以及与软骨修復和再生手术相关的风险和併发症限制了市场的开拓。软骨再生装置的技术进步正在提高再生治疗的有效性。此外，对软骨再生的持续研究和开发正在扩大其成长潜力。

主要市场统计
基准年[2023] 18.3亿美元
预测年份 [2024] 20.6亿美元
预测年份 [2030] 44.6亿美元
复合年增长率（%） 13.55%

治疗模式 年轻患者首选细胞治疗方法

细胞疗法使用活细胞来修復和再生软骨组织。这些治疗方法通常利用软骨细胞和可分化为软骨细胞的间质干细胞。使用细胞的软骨细胞移植是针对软骨缺陷和损伤的先进医学治疗方法，通常用于局部软骨缺陷的患者。这个过程包括从患者体内收集健康的软骨细胞，在实验室中培养这些细胞，然后将它们重新移植到受伤部位。生长因子技术应用已知可促进细胞（包括软骨细胞）生长和分化的特定蛋白质。这些生物分子可以透过多种方式施用，包括注射或植入支架。另一方面，无细胞治疗方法包括不直接使用活细胞的治疗方法，例如有助于软骨自然修復过程的组织支架和生长因子。无细胞复合材料是指无需直接使用活细胞即可实现软骨组织再生的生物材料。相反，这些材料旨在模拟细胞外基质并支持天然细胞迁移和增殖到缺陷部位。组织支架是3D结构，为新软骨组织的生长和发育提供支持环境。这些支架可以是生物分解性的或非生物分解的，并由多种材料製成，包括天然和合成聚合物、陶瓷和复合材料。

普及透明软骨疗法，实现高效关节运动

纤维软骨是一种坚韧、緻​​密的纤维软骨组织，存在于椎间盘、半月软骨和耻骨联合等身体部位。其特征是由不同比例的白色纤维组织和软骨组织混合而成。由于其高拉伸强度和有限的血液供应，纤维软骨的内在癒合潜力有限，因此需要开发专门的修復技术。透明质酸软骨是一种透明、有光泽的关节软骨，可以保护关节的骨骼。它为关节运动提供光滑、低摩擦的表面，并有助于有效分配负荷。透明质酸软骨受损会导致关节疼痛、僵硬和骨关节炎等症状。其缺血性性质对修復和再生提出了重大挑战。纤维软骨和透明质酸软骨修復的比较表明，由于解剖和功能差异，两者都需要不同的方法。透明质软骨广泛存在于所有滑液关节中，对关节功能很重要，而纤维软骨纤维较多，存在于身体的较少区域。纤维软骨损伤更常见于特定区域，例如膝盖或骨盆，而不是影响许多关节的透明软骨问题。

最终用户：由于复杂手术所需的先进设备和材料的存在，软骨修復/软骨再生在医院的应用正在增加。

门诊手术中心 (ASC) 是提供当天手术治疗（包括诊断和预防程序）的医疗保健机构。在软骨修復和再生领域，ASC 因其成本效益和便利性而成为越来越受患者欢迎的选择。我们提供门诊软骨修復和再生服务，包括整形外科和运动医学诊所等专科诊所。由于这些设施比医院小，因此它们通常提供更个人化的患者护理方法。该医院是一家综合医疗机构，提供广泛的医疗服务，包括高级软骨修復和再生所需的复杂手术。门诊手术中心为小手术提供高效且具成本效益的解决方案，诊所提供个人化的非侵入性治疗，而医院则提供全面的护理和复杂的手术。提供者和製造商之间的合作继续推动技术进步并改善所有这些医疗保健环境中的患者治疗结果。

区域洞察

由于其完善的医疗基础设施、有利的报销方案以及主要市场参与者的存在，美国在采用创新软骨修復解决方案方面处于领先地位。儘管面临资源有限和医疗保健环境不利的报销环境等挑战，巴西和墨西哥等国家也显示出市场成长潜力。亚太地区正在迅速崛起，成为软骨修復和再生领域的主要参与者。这一增长的推动因素包括可支配收入的增加、医疗保健行业的扩张、对软骨再生程序的认识不断提高以及与生活方式相关的关节疾病患病率的上升。欧洲是 EMEA 软骨修復和再生市场的关键地区，拥有先进的医疗保健系统、高昂的医疗成本和强大的法规结构。大型医疗保健公司的存在以及对研发的大量投资正在推动软骨修復疗法的创新。同时，由于医疗保健的取得和品质存在巨大差异，中东和非洲的成长正在放缓。

FPNV定位矩阵

FPNV定位矩阵对于评估软骨修復/软骨再生市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对软骨修復/软骨再生市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.软骨修復/软骨再生市场的市场规模和预测是多少？

2.在软骨修復/软骨再生市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.软骨修復/软骨再生市场的技术趋势和法规结构是什么？

4.软骨修復/软骨再生市场主要厂商的市场占有率是多少？

5.进入软骨修復/软骨再生市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 关节炎和骨关节炎等骨关节疾病的盛行率
      • 交通事故和运动相关伤害的数量正在迅速增加。
      • 提高对软骨生理学、解剖学和修復技术的认识
    • 抑制因素
      • 软骨修復手术相关的高成本
    • 机会
      • 软骨再生装置的技术进步
      • 持续研究和开发软骨再生
    • 任务
      • 与软骨修復/软骨再生手术相关的风险和併发症
  • 市场区隔分析
    • 治疗模式：年轻患者首选细胞治疗方法
    • 应用：更广泛地使用透明软骨疗法来实现有效的关节运动
    • 最终用户：由于复杂手术所需的先进设备和材料的存在，软骨修復/软骨再生在医院环境中的应用正在增加。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依治疗模式分類的软骨修復/软骨再生市场

  • 基于细胞的
  • 非细胞基础

第七章软骨修復/软骨再生市场：依应用分类

  • 纤维软骨
  • 透明软骨

第八章软骨修復/软骨再生市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院

第九章 北美和南美软骨修復/软骨再生市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太软骨修復/软骨再生市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲软骨修復/软骨再生市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 施乐辉获得用于运动医学膝盖修復的新软骨再生技术
    • FDA核准CartiHeal植入治疗软骨和骨软骨缺陷
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4103B31E00C5

[190 Pages Report] The Cartilage Repair/Cartilage Regeneration Market size was estimated at USD 1.83 billion in 2023 and expected to reach USD 2.06 billion in 2024, at a CAGR 13.55% to reach USD 4.46 billion by 2030.

Cartilage repair and regeneration refers to a range of medical treatments and procedures aimed at restoring function and relieving pain in damaged joint cartilage. Cartilage is a resilient and smooth elastic tissue. This rubber-like padding covers and protects the ends of long bones at the joints and is a structural component of the rib cage, the ear, the nose, the bronchial tubes, the intervertebral discs, and many other body components. The cartilage repair/regeneration market encompasses medical procedures, tools, and treatments designed to repair, regenerate, or replace damaged cartilage. The prevalence of bone and joint disorders such as arthritis or osteoarthritis and the surge in the number of road accidents and sports-related injuries are driving the market growth. Rising awareness about cartilage physiology, anatomy, and repair techniques is also a fuel market. The costs associated with cartilage repair surgeries and the risks and complications involved in cartilage repair/regeneration procedures are restricting market development. Technological advancements in cartilage regeneration equipment are enhancing the efficacy of regenerative treatments. In addition, continuous research and development for cartilage regeneration are expanding its growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 1.83 billion
Estimated Year [2024] USD 2.06 billion
Forecast Year [2030] USD 4.46 billion
CAGR (%) 13.55%

Treatment Mode: Significant preference cell-based therapies for younger patients

Cell-based therapies involve using living cells to repair or regenerate cartilage tissue. These treatments often utilize chondrocytes or mesenchymal stem cells that can differentiate into cartilage cells. Cell-based chondrocyte transplantation represents an advanced medical treatment for cartilage defects and damage, typically employed in patients with localized cartilage loss. This process involves harvesting healthy cartilage cells from the patient's body, laboratory expansion of these cells, and subsequent reimplantation into the damaged area. Growth factor technology involves applying specific proteins known to enhance the growth and differentiation of cells, including chondrocytes. These biological molecules can be delivered through various methods, such as injections or embedded within scaffolds. On the other hand, non-cell-based therapies include treatments that do not directly involve living cells, such as tissue scaffolds and growth factors that aid in the natural process of cartilage repair. Cell-free composites are biomaterials that enable cartilage tissue regeneration without the direct use of living cells. Instead, these materials are engineered to mimic the extracellular matrix and support the migration and proliferation of native cells to the defect site. Tissue scaffolds are 3D structures that provide a supportive environment for the growth and development of new cartilage tissue. These scaffolds can be biodegradable or non-biodegradable and may be made from various materials, including natural and synthetic polymers, ceramics, or composites.

Application: Wider use of hyaline cartilage therapies for efficient joint movement

Fibrocartilage is a tough, dense, and fibrous type of cartilage tissue found in areas of the body, such as the intervertebral discs, menisci, and pubic symphysis. Various proportions of white fibrous tissue and cartilaginous tissue characterize it. Due to its high tensile strength and limited blood supply, fibrocartilage has limited intrinsic healing capability, which necessitates the development of specialized repair techniques. Hyaline cartilage is a transparent, glossy articular cartilage that protects the bones in joints. It provides a smooth, low-friction surface for joint movement and helps to distribute load effectively. Damage to hyaline cartilage can lead to joint pain, stiffness, and conditions like osteoarthritis. Its avascular nature poses significant challenges for repair and regeneration. When comparing fibrocartilage and hyaline cartilage repair, it is evident that both require distinct approaches due to their anatomical and functional differences. While fibrocartilage is more fibrous and is found in fewer body regions, hyaline cartilage is prevalent in all synovial joints and is critical for joint function. Fibrocartilage injuries are commonly associated with specific sites, such as the knee and pelvic region, instead of hyaline cartilage issues, which can affect many joints.

End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures

Ambulatory surgery centers(ASCs) are healthcare establishments that deliver same-day surgical care, including diagnostic and preventive procedures. In cartilage repair and regeneration, ASCs are an increasingly popular choice for patients due to their cost-effectiveness and convenience. Clinics, including those specialized, such as orthopedic or sports medicine clinics, offer outpatient cartilage repair and regeneration services. These facilities often provide a more personalized approach to patient care due to their smaller scale than hospitals. Hospitals are comprehensive medical facilities that offer a wide range of healthcare services, including complex surgeries required for advanced cartilage repair and regeneration. Ambulatory Surgery Centers offer efficient and cost-effective solutions for minor procedures, Clinics provide personalized and non-invasive treatments, and Hospitals are equipped for comprehensive care and complex surgeries. Collaborations among providers and manufacturers continue to drive technological advancements and improve patient outcomes in all these healthcare settings.

Regional Insights

The United States leads the region in the adoption of innovative cartilage repair solutions due to well-established healthcare infrastructure, favorable reimbursement scenarios, and the presence of key market players. Countries such as Brazil and Mexico also show potential for market growth, albeit with challenges such as resource limitations in healthcare settings and less favorable reimbursement environments. The Asia-Pacific region is rapidly emerging as a significant cartilage repair and regeneration player. This growth is propelled by increasing disposable incomes, an expanding healthcare sector, growing awareness about cartilage regeneration procedures, and the rising prevalence of lifestyle-related joint disorders. Europe is a major EMEA cartilage repair/regeneration market region, supported by sophisticated healthcare systems, high healthcare expenditure, and strong regulatory frameworks. The presence of leading healthcare companies and substantial investments in research and development fosters innovation in cartilage repair therapies. In contrast, the Middle East and Africa exhibit slower growth with significant healthcare access and quality disparities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cartilage Repair/Cartilage Regeneration Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cartilage Repair/Cartilage Regeneration Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex GmbH, B. Braun SE, Collagen Solutions Ltd., CONMED Corporation, Geistlich Pharma AG, Medical Device Business Services, Inc., MEDIPOST Co., Ltd., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cartilage Repair/Cartilage Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Mode
    • Cell-Based
      • Chondrocyte Transplantation
      • Growth Factor Technology
    • Non-Cell-Based
      • Cell-Free Composites
      • Tissue Scaffolds
  • Application
    • Fibrocartilage
    • Hyaline Cartilage
  • End-User
    • Ambulatory Surgery Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cartilage Repair/Cartilage Regeneration Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cartilage Repair/Cartilage Regeneration Market?

3. What are the technology trends and regulatory frameworks in the Cartilage Repair/Cartilage Regeneration Market?

4. What is the market share of the leading vendors in the Cartilage Repair/Cartilage Regeneration Market?

5. Which modes and strategic moves are suitable for entering the Cartilage Repair/Cartilage Regeneration Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of bone and joint disorders such as arthritis or osteoarthritis
      • 5.1.1.2. Surge in number of road accidents and sports-related injuries
      • 5.1.1.3. Rising awareness about cartilage physiology, anatomy, and repair techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cartilage repair surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cartilage regeneration equipment
      • 5.1.3.2. Continuous research and development for cartilage regeneration
    • 5.1.4. Challenges
      • 5.1.4.1. Risks and complications involved in cartilage repair/cartilage regeneration procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Mode: Significant preference cell-based therapies for younger patients
    • 5.2.2. Application: Wider use of hyaline cartilage therapies for efficient joint movement
    • 5.2.3. End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cartilage Repair/Cartilage Regeneration Market, by Treatment Mode

  • 6.1. Introduction
  • 6.2. Cell-Based
  • 6.3. Non-Cell-Based

7. Cartilage Repair/Cartilage Regeneration Market, by Application

  • 7.1. Introduction
  • 7.2. Fibrocartilage
  • 7.3. Hyaline Cartilage

8. Cartilage Repair/Cartilage Regeneration Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Cartilage Repair/Cartilage Regeneration Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair
    • 12.3.2. FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
  • FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 136. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 146. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 156. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 166. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 176. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 186. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 196. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 206. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 216. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 226. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 247. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 248. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 258. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 268. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 278. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 288.